Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 804 results for "Director From Pfizer"

Pfizer's board announces 8% escalation in Q1 2015 dividend

The board of directors of Pfizer This dividend will be paid on 3 March 2015 to shareholders of record at the close of business as of 6 February 2015. According to the company, it has increased the dividend by approximately 8% to USD0.28 per share ... BusinessWeek, 2 days ago

9 images for Director From Pfizer

Jutia Group, 2 days ago, 1 week ago, 2 weeks ago
Citybizlist, 1 week ago
TMC Net, 1 week ago
Canada NewsWire, 2 weeks ago
Astro Awani, 1 month ago
KXXV-TV, 2 months ago
Securities Technology Monitor, 2 months ago
Business Standard India

Pfizer, Wyeth jump ahead of amalgamation

Pfizer and Wyeth are trading higher on the BSE ahead of amalgamation. The board of directors of Pfizer has fixed 11, December as the "Record Date" to determine the name of equity shareholders of Wyeth who shall be entitled to receive shares of the ...
 India Infoline1 week ago Pfizer, Wyeth hit new high ahead of amalgamation  Business Standard India1 week ago
Jutia Group

Pfizer Declares First-Quarter 2015 Dividend

The board of directors of Pfizer declared a 28-cent first-quarter 2015 dividend on the company's common stock, payable March 3, 2015, to shareholders of record at the close of business on February 6, 2015. According to a company release, Pfizer ...
 Individual.com6 hours ago Company Update (NYSE:PFE): Pfizer Declares First-Quarter 2015 Dividend  Tamar Securities2 days ago PFIZER : Declares First-Quarter 2015 Dividend  4 Traders2 days ago Stock Update: Amgen Inc (NASDAQ:AMGN) Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend  Jutia Group11 hours ago

SFI announces €1.9m in funding in partnership with Pfizer

Mark Ferguson, director general of SFI, Minister Damien English, Prof James O'Donnell, Trinity College Dublin and Dr William Finlay, director of global biotherapeutics technologies Science Foundation Ireland (SFI) has announced funding of €1.9m ...
 Business & Leadership1 day ago SFI and Pfizer announce €1.9m fund for 5 Irish researchers  FirstWord Pharma1 day ago SFI and Pfizer link in E1.9m research  Ireland Business World2 days ago

Venkatadri Bobba joins Cancer Genetics India's Board of Directors

Bobba has over 36 years of corporate leadership experience in the pharma and life sciences industries Cancer Genetics, provider of DNA-based cancer diagnostics, has announced the addition of Venkatadri Bobba to Cancer Genetics India's Board of ...
 Financial Express1 day ago Cancer Genetics, Inc. Announces Appointment of Venkatadri Bobba to Cancer Genetics India's Board of Directors  CEOWorld Magazine2 days ago
Irish Times

New awards scheme launched for biomedical research

Science Foundation Ireland and drug giant Pfizer have agreed create an awards programme in support of biomedical research. The funds provided will support the work of five scientists from four Irish universities to help move research discoveries ...
 Irish Times1 day ago

Sucampo names John H. Johnson to board

Biopharmaceutical company Sucampo Pharmaceuticals Currently, Johnson is a member of the board of directors of Cempra Pharmaceuticals, Histogenics and Portola Pharmaceuticals. He is the founder of Plum Brook Advisors. Recently, Johnson has served ...
 BusinessWeek2 days ago

Tenet Healthcare appoints new director

Tenet Healthcare Corporation, an operator of acute care hospitals and outpatient centers, has appointed Freda Lewis-Hall, executive vice president and chief medical officer of Pfizer Inc., as a new independent director. Dr Lewis-Hall joined Pfizer ...
 Individual.com3 days ago Tenet Healthcare : Names Freda Lewis-Hall to Board of Directors  4 Traders1 week ago

Pfizer Inks Gene Therapy Partnership With Spark Therapeutics

By Estel Grace Masangkay Pfizer announced two major moves that will expand its rare disease R&D activities. First, the company said it will establish a gene therapy platform through its newly inked agreement with Spark Therapeutics . Secondly, it ...
 Bioresearch Online6 days ago Pfizer to Intensify AAV Vector Research in Gene Therapy for Hemophilia  PharmTech.com1 week ago Pfizer buys into gene therapy  Pharmafocus1 week ago PFIZER : Expands Rare Disease Research and Development Activities  4 Traders6 days ago

Sucampo Appoints John H. Johnson to Board of Directors

BETHESDA, Md., Dec. 15, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced the appointment of John H. Johnson, founder, Plum Brook Advisors, to its board of directors ...
 Stock Nod3 days ago Appoints Timothy P. Cost to Board of Directors  Noodls3 days ago WEB : Appoints Timothy P. Cost to Board of Directors  4 Traders3 days ago appoints Cost to board of directors  Telecompaper1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less